Skip to content
Screener

Establishment Labs ESTA Financing Cash Flow

Financing Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-$8.78B-54.9%
AbbVie logo
AbbVieABBV
$919M+173%
IAR
Integra LifeSciencesIART
$8.3M-76.5%
Artivion logo
ArtivionAORT
$152.39M+5,766%
Globus Medical logo
Globus MedicalGMED
-$134.5M-439%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$2.45M-7.2%

Other financials

Income statement

See full
Revenue$67.5M+31.7%
Gross profit$47.7M+35.3%
Operating income-$4.3M+69.6%
Net income-$11.7M+29.2%
EPS (diluted)-$0.39+31.6%

Balance sheet

See full
Cash & equivalents$71.2M+30.2%
Total debt$263.7M+14.1%
Total equity$21.6M-5.1%
Total assets$351.9M+6.8%

Cash flow

See full
Operating cash flow-$16.6M+11.5%
CapEx$3.7M+125%
Free cash flow-$20.3M+0.6%

Valuation

See full
Market cap$2.24B+130%
Enterprise value$2.43B+111%
P/S9.1×+3.6×

Profitability

See full
Gross margin70.5%+3.3pp
Operating margin-7.6%-3.4pp
Net margin-15.8%-6.4pp
FCF margin-16.9%-6.4pp

Returns & leverage

See full
Return on equity-175.3%-43.4pp
Debt / equity12.2×+2.1×
Current ratio3.8×+1.0×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Establishment Labs’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001688757-26-000050
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Repayments of short-term notes payable for insurance premium financing(1,981)
Proceeds from stock option exercises16,930352
Tax payments related to shares withheld upon vesting of restricted stock(977)(426)
Net cash provided by financing activities22,5994,926
Effect of exchange rate changes on cash and cash equivalents(493)2,251
Net decrease in cash and cash equivalents(4,415)(35,708)
Cash and cash equivalents at beginning of period75,57290,347
Cash and cash equivalents at end of period$71,157$54,639

Item 1. Financial Statements - Unaudited

FAQ

What is Establishment Labs's financing cash flow?
Establishment Labs (ESTA) reported financing cash flow of $23.46M in Q2 2026.
How has Establishment Labs's financing cash flow changed year-over-year?
Establishment Labs's financing cash flow increased by 357.5% year-over-year, from $5.13M to $23.46M.
What is the long-term trend for Establishment Labs's financing cash flow?
Over 4 years (2021 to 2025), Establishment Labs's financing cash flow has grown at a 77.7% compound annual growth rate (CAGR), from $4.05M to $40.43M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Establishment Labs's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude